This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (14)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Cataracts/ Lens  • Articles for Residents  • Glaucoma  • Alert me on articles by topic

AGIS Investigators

Arch Ophthalmol. 2000;118:1639-1652.

Objective  To investigate the effect of cataract on visual function and the role of cataract in explaining a race-treatment interaction in outcomes of glaucoma surgery.

Methods  The Advanced Glaucoma Intervention Study (AGIS) enrolled 332 black patients (451 eyes) and 249 white patients (325 eyes) with advanced glaucoma. Eyes were randomly assigned to an argon laser trabeculoplasty (ALT)-trabeculectomy-trabeculectomy sequence or a trabeculectomy-ALT-trabeculectomy sequence. From the AGIS experience with cataract surgery during follow-up, we estimated the expected change in visual function scores from before cataract surgery to after cataract surgery. Then, for eyes with cataract not removed, we used these estimates of expected change to adjust visual function scores for the presumed effects of cataract. In turn, we used the adjusted scores to obtain cataract-adjusted main outcome measures.

Main Outcome Measures  Average percent of eyes with decrease of visual field (APDVF) and average percent of eyes with decrease of visual acuity (APDVA).

Results  Within the 2 months before cataract surgery, visual acuity was better in eyes of white patients than of black patients by an average of approximately 2 lines on the visual acuity test chart. Cataract surgery improved visual acuity and visual field defect scores, with the amounts of improvement greater when preoperative visual acuity was lower. Adjustments for cataract brought about the following relative reductions: for APDVF, a relative reduction of 5% to 11% in black patients and 9% to 11% in white patients; for APDVA, a relative reduction of 45% to 49% in black patients and 31% to 38% in white patients; and for the APDVF and APDVA race-treatment interactions, relative reductions of 25% and 45%, respectively.

Conclusions  On average, visual function scores improved after cataract surgery. The findings of reduced race-treatment interactions after adjustment for cataract do not alter our earlier conclusion that the AGIS 7-year results support use of the ALT-trabeculectomy-trabeculectomy sequence for black patients and of the trabeculectomy-ALT-trabeculectomy sequence for white patients without life-threatening health problems. The choice of treatment should take into account individual patient characteristics and needs.

From the Advanced Glaucoma Intervention Study Coordinating Center, Potomac, Md.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Estimating the Rate of Progressive Visual Field Damage in Those with Open-Angle Glaucoma, from Cross-Sectional Data
Broman et al.
IOVS 2008;49:66-76.
ABSTRACT | FULL TEXT  

Rarebit Perimetry in Normal Subjects: Test Retest Variability, Learning Effect, Normative Range, Influence of Optical Defocus, and Cataract Extraction
Salvetat et al.
IOVS 2007;48:5320-5331.
ABSTRACT | FULL TEXT  

Cataract Extraction in the Collaborative Initial Glaucoma Treatment Study: Incidence, Risk Factors, and the Effect of Cataract Progression and Extraction on Clinical and Quality-of-Life Outcomes
Musch et al.
Arch Ophthalmol 2006;124:1694-1700.
ABSTRACT | FULL TEXT  

Poor Uptake of Cataract Surgery in Nursing Home Residents: The Salisbury Eye Evaluation in Nursing Home Groups Study
Friedman et al.
Arch Ophthalmol 2005;123:1581-1587.
ABSTRACT | FULL TEXT  

Racial Variations in Causes of Vision Loss in Nursing Homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study
Friedman et al.
Arch Ophthalmol 2004;122:1019-1024.
ABSTRACT | FULL TEXT  

Causes and Prevalence of Visual Impairment Among Adults in the United States
The Eye Diseases Prevalence Research Group
Arch Ophthalmol 2004;122:477-485.
ABSTRACT | FULL TEXT  

Reduction of Intraocular Pressure and Glaucoma Progression: Results From the Early Manifest Glaucoma Trial
Heijl et al.
Arch Ophthalmol 2002;120:1268-1279.
ABSTRACT | FULL TEXT  

The Advanced Glaucoma Intervention Study, 8: Risk of Cataract Formation After Trabeculectomy
The AGIS Investigators
Arch Ophthalmol 2001;119:1771-1779.
ABSTRACT | FULL TEXT